Russell Investments Group, Ltd. Provention Bio, Inc. Transaction History

Russell Investments Group, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$6.7 - $24.21 $2,103 - $7,601	314 Added 0.47%	67,647 $1.63 Million
Q2 2022 Jul 29, 2022	BUY	$3.65 - $7.3 $245,765 - $491,530	67,333 New	67,333 $269,000
Q3 2020 Nov 09, 2020	SELL	$10.34 - $15.2 $814,337 - $1.2 Million	-78,756 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$7.81 - $17.0 $615,084 - $1.34 Million	78,756 New	78,756 $1.11 Million

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.